Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms 8Stomach Neoplasms 7Lung Neoplasms 7Small Cell Lung Carcinoma 5Rectal Neoplasms 5Pancreatic Neoplasms 5Colorectal Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Esophageal Squamous Cell Carcinoma 4Recurrence 3NSCLC 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Muscle-invasive Bladder Cancer 2Multiple Myeloma 2Mesothelioma, Malignant 2Limited Stage Small Cell Lung Cancer 2Leukemia, Myeloid, Acute 2Esophageal Neoplasms 2Urologic Neoplasms 1Upper Tract Urothelial Carcinoma 1Thymus Neoplasms 1Sleep Initiation and Maintenance Disorders 1Resectable Non-small Cell Lung Cancer 1Pathologic Complete Response 1

Interventions

Drug Therapy 2trilaciclib 1anlotinib 1Surgical Procedures, Operative 1Sodium Chloride 1Radiotherapy 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Limited Stage Small Cell Lung Cancer × Drug Therapy × Clear all
NCT06978153 2025-05-18

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Combined With Chemotherapy With or Without Anlotinib in Resectable Limited-Stage Small Cell Lung Cancer

Tang-Du Hospital

Phase 2 Not yet recruiting
66 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

NCT05496166 2023-05-17

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 3 Not yet recruiting
348 enrolled
Thoracic

Limited Stage Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡